[1] PASTUKH N,MEERSON A,KALISH D,et al.Serum miR-122 levels correlate with diabetic retinopathy[J]. Clin Exp Med,2019,19(2):255-260. [2] ZHOU Y Q,XIA Z C,CHENG Z K,et al.Inducible microRNA-590-5p inhibits host antiviral response by targeting the soluble interleukin-6 (IL6) receptor[J].J Biol Chem,2018,293(47):18168-18179. [3] LIU H N,LI X,WU N,et al.Serum microRNA-221 as a biomarker for diabetic retinopathy in patients associated with type 2 diabetes[J].Int J Ophthalmol,2018,11(12):1889-1894. [4] CASSIDY F C,SHORTISS C,MURPHY C G,et al.Impact of type 2 diabetes mellitus on human bone marrow stromal cell number and phenotypic characteristics[J]. Int J Mol Sci,2020,21(7):2476. [5] KHAN M A,HASHIM M J,MUSTAFA H,et al.Global epidemiology of ischemic heart disease:results from the global burden of disease study[J]. Cureus,2020,12(7):e9349. [6] GAUDINO M,HAMEED I,FARKOUH M E,et al.Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery:a meta-analysis[J]. JAMA Intern Med,2020,180(12):1638-1646. [7] AHMAD Y,HOWARD J P,ARNOLD A D,et al.Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease:a meta-analysis of randomized controlled trials[J].Eur Heart J,2020,41(34):3228-3235. [8] 王佳,李青伟,杨映映,等. 仝小林防治早期糖尿病视网膜病变经验[J]. 北京中医药,2017,36(6):512-515. [9] 李雪,张萍.糖尿病视网膜病变的临床治疗新进展[J]. 国际眼科杂志,2019,19(1):69-72. [10] ZHANG Y,SUN X H,ICLI B,et al.Emerging roles for microRNAs in diabetic microvascular disease:novel targets for therapy[J]. Endocr Rev,2017,38(2):145-168. [11] 倪妙玲,金智生.糖尿病视网膜病变的中医临床治疗进展[J]. 中医研究,2019,32(7):78-80. [12] 刘芳,杜郁华,陈雁.中医适宜技术治疗糖尿病视网膜病变100例的临床观察[J].中国实用医药,2019,14(2):118-119. [13] CHIEN H Y,CHEN C Y,CHIU Y H,et al.Differential microRNA profiles predict diabetic nephropathy progression in Taiwan[J]. Int J Med Sci,2016,13(6):457-465. [14] ZHAI C N,CONG H L,HOU K,et al.Clinical outcome comparison of percutaneous coronary intervention and bypass surgery in diabetic patients with coronary artery disease:a meta-analysis of randomized controlled trials and observational studies[J].Diabetol Metab Syndr,2019,11:110. [15] JI H H,YI Q Y,CHEN L S,et al.Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy[J]. Clin Chim Acta,2020,501:147-153. [16] WU J H,GAO Y,REN A J,et al.Altered microRNA expression profiles in retinas with diabetic retinopathy[J]. Ophthalmic Res,2012,47(4):195-201. [17] 黄国强,梁栋,陈玉敏,等. 我院糖尿病人群常规筛查糖尿病性视网膜病变的危险因素分析[J]. 中国现代医生,2021,59(18):61-64. [18] 张危,丁超,赖娇.尿微量白蛋白/尿肌酐比值与2型糖尿病视网膜病变严重程度的相关关系[J].中外医疗,2021,40(5):14-17. [19] 孙东海. 老年2型糖尿病患者视网膜病变与糖化白蛋白的关系探讨[J]. 中国老年保健医学,2019,17(4):75-77. |